Stock Quote        
  Join        Login  
logo

Novo Nordisk Honored as a Best Place to Work in New Jersey

Thursday, April 26, 2012 9:00 AM

Pharmaceuticals leader ranks in top four for eighth year; second top employer recognition in 2012

PRINCETON, N.J., April 26, 2012 /PRNewswire/ -- Novo Nordisk Inc. (NYSE: NVO), a global healthcare company with 89 years of innovation and leadership in diabetes care, was named as one of the "Best Places to Work in New Jersey" by NJBIZ, the state's largest weekly business journal. This is the eighth time Novo Nordisk has appeared on the annual list. Earlier this year, Novo Nordisk was recognized for the fourth straight year as one of FORTUNE Magazine's "100 Best Companies to Work For."

(Logo: http://photos.prnewswire.com/prnh/20110414/NY80976LOGO )

The "Best Places to Work in New Jersey" ranking is a prestigious recognition of New Jersey-based companies that show a dedication to their employees' growth and quality of life. Novo Nordisk has approximately 1,200 employees in the state, supporting a nationwide network of field-based sales, medical and research staff.

"Investing in our employees means we can do more to improve care to our patients," said Jeff Frazier, Corporate Vice President of Human Resources of Novo Nordisk Inc.  "Novo Nordisk recognizes that our employees are the key to everything that we do. Without the intense passion and focus of our staff here in New Jersey and across the U.S., we would not be as successful as we are today in making a national impact on diabetes and other chronic diseases."

Novo Nordisk offers employees exceptional compensation and an array of benefits programs, including:

  • Pay-for-performance plans;
  • Workplace flexibility;
  • Generous paid time off; and
  • Robust 401k and retirement plans.

Other organizations recognizing Novo Nordisk's corporate practices and culture include Corporate Knight, Conceive Magazine, Working Mother Magazine and the Dave Thomas Foundation's Best Adoption-Friendly Workplaces.

The full rankings will appear in a supplement to the April 30, 2012 issue and online at www.njbiz.com.

About Novo Nordisk
Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 32,500 employees in 74 countries, and markets its products in 179 countries. For more information, visit www.novonordisk-us.com.

About NJBIZ's "Best Places to Work in New Jersey"
Companies from across the state entered the two-part process to determine the 100 Best Places to Work in New Jersey. The first part consisted of evaluating each nominated company's workplace policies, practices, philosophy, systems and demographics. This phase was worth approximately 25% of the total evaluation. The second part consisted of an employee survey to measure the employee experience. This phase was worth approximately 75% of the total evaluation. The combined scores determined the top companies and the final ranking. The overall registration and survey process was managed by Best Companies Group (BCG).  BCG also analyzed the data provided and used their expertise to determine the final rankings.

SOURCE Novo Nordisk Inc.

(Source: PR Newswire )
(Source: Quotemedia)

Follow iStockAnalyst on Twitter Follow iStockAnalyst on Twitter
Subscribe to Email Alerts
Advertisement
Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 




Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.